Abstract Context The European Association of Urology (EAU) guidelines panel on upper
urinary tract urothelial carcinoma (UTUC) has updated the guidelines to aid clinicians in …

Context Treatment of metastatic urothelial carcinoma is currently undergoing a rapid
evolution. Objective This overview presents the updated European Association of Urology …

Urothelial carcinoma (UC), also described as bladder cancer, is the 10th most common
cancer type worldwide, with an estimated 549 000 new cases and 200 000 deaths in 2018 …

Abstract Context The European Association of Urology (EAU) Guidelines Panel on Upper
Urinary Tract Urothelial Carcinoma (UTUC) has prepared updated guidelines to aid …

Background The role of adjuvant treatment in high-risk muscle-invasive urothelial carcinoma
after radical surgery is not clear. Methods In a phase 3, multicenter, double-blind …

Purpose: The purpose of this guideline is to provide a useful reference on the effective
evidence-based diagnoses and management of non-metastatic upper tract urothelial …

Background Despite standard curative-intent treatment with neoadjuvant cisplatin-based
chemotherapy, followed by radical surgery in eligible patients, muscle-invasive urothelial …

Context To improve the prognosis of upper tract urothelial carcinoma (UTUC), clinicians
have used neoadjuvant chemotherapy (NAC) or adjuvant chemotherapy (AC) before or after …

Solid cancers comprise a large number of new cases and deaths from cancer each year
globally. There are a number of strategies for addressing tumors raised from solid organs …

PURPOSE Neoadjuvant chemotherapy (NAC) has proven survival benefits for patients with
invasive urothelial carcinoma of the bladder, yet its role for upper tract urothelial carcinoma …